MARCO MARCELLI's research topics

MARCO MARCELLI

Concepts (400)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with MARCO MARCELLI's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that MARCO MARCELLI has written about over time.

Prostatic Hyperplasia, 3 publications between 1997 and 2000, average publication date March 1999. Caspases, 5 publications between 1998 and 2001, average publication date December 1999. Staurosporine, 4 publications between 1999 and 2001, average publication date March 2000. Proto-Oncogene Proteins c-bcl-2, 7 publications between 1999 and 2004, average publication date September 2001. Apoptosis, 13 publications between 1997 and 2009, average publication date March 2002. Prostatic Neoplasms, 20 publications between 1995 and 2016, average publication date October 2002. Androgens, 10 publications between 1992 and 2016, average publication date March 2004. Androgen-Insensitivity Syndrome, 3 publications between 1992 and 2011, average publication date August 2004. Receptors, Androgen, 26 publications between 1992 and 2021, average publication date October 2004. Transcription, Genetic, 7 publications between 2003 and 2016, average publication date April 2009. Androgen Receptor Antagonists, 5 publications between 2005 and 2016, average publication date November 2009. Precision Medicine, 2 publications between 2009 and 2011, average publication date June 2010. Cachexia, 3 publications between 2005 and 2023, average publication date October 2012. High-Throughput Screening Assays, 2 publications between 2009 and 2016, average publication date May 2013. Testosterone, 6 publications between 1997 and 2021, average publication date August 2014. Genetic Variation, 3 publications between 2012 and 2016, average publication date February 2015. Hypogonadism, 3 publications between 2006 and 2021, average publication date November 2015. Hydroxamic Acids, 1 publications between 2016 and 2016, average publication date March 2016. Quinazolines, 1 publications between 2016 and 2016, average publication date March 2016. Practice Guidelines as Topic, 1 publications between 2020 and 2020, average publication date January 2020.

Prostatic Hyperplasia
Caspases
Staurosporine
Proto-Oncogene Proteins c-bcl-2
Apoptosis
Prostatic Neoplasms
Androgens
Androgen-Insensitivity Syndrome
Receptors, Androgen
Transcription, Genetic
Androgen Receptor Antagonists
Precision Medicine
Cachexia
High-Throughput Screening Assays
Testosterone
Genetic Variation
Hypogonadism
Hydroxamic Acids
Quinazolines
Practice Guidelines as Topic

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Prostatic Hyperplasia	3	1997	2000	March 1999
Caspases	5	1998	2001	December 1999
Staurosporine	4	1999	2001	March 2000
Proto-Oncogene Proteins c-bcl-2	7	1999	2004	September 2001
Apoptosis	13	1997	2009	March 2002
Prostatic Neoplasms	20	1995	2016	October 2002
Androgens	10	1992	2016	March 2004
Androgen-Insensitivity Syndrome	3	1992	2011	August 2004
Receptors, Androgen	26	1992	2021	October 2004
Transcription, Genetic	7	2003	2016	April 2009
Androgen Receptor Antagonists	5	2005	2016	November 2009
Precision Medicine	2	2009	2011	June 2010
Cachexia	3	2005	2023	October 2012
High-Throughput Screening Assays	2	2009	2016	May 2013
Testosterone	6	1997	2021	August 2014
Genetic Variation	3	2012	2016	February 2015
Hypogonadism	3	2006	2021	November 2015
Hydroxamic Acids	1	2016	2016	March 2016
Quinazolines	1	2016	2016	March 2016
Practice Guidelines as Topic	1	2020	2020	January 2020

MARCELLI's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (400)

Explore

Co-Authors (42)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors